A combined analysis of EORTC/MRC randomized clinical trials for the prophylactic treatment of TaT1 bladder cancer. Eortc Genito-Urinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer.

Acta urologica Belgica

Volumn 64, Issue 2, 1996, Pages 27-

  Pawinski, A ^a   Sylvester, R ^a   Bouffioux, C ^a   Kurth, K H ^a   Parmar, M ^a   Bijnens, L ^a  

^a Surgery Division   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; BLADDER TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TRANSITIONAL CELL CARCINOMA;

ADMINISTRATION, INTRAVESICAL; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; HUMANS; RANDOMIZED CONTROLLED TRIALS; URINARY BLADDER NEOPLASMS;

EID: 0030141197     PISSN: 00017183     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)